Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Molecular Pharmacology|October 24, 2003
Ceramide is involved in r(+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cellsRobert Ramer, Ulrike Weinzierl, Bianca Schwind, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 27, 2020
A simple LC-MS/MS method for the simultaneous quantification of endocannabinoids in biological samplesMaria Bobrich, Rico Schwarz, Robert Ramer, et al.Oncotarget|October 23, 2018
The antiangiogenic action of cisplatin on endothelial cells is mediated through the release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cellsRobert Ramer, Tilman Schmied, Christin Wagner, et al.Pharmaceutical Research|July 30, 2010
Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cellsRobert Ramer, Anja Rohde, Jutta Merkord, et al.Biochemical Pharmacology|July 1, 2014
Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cellsRobert Ramer, Sascha Fischer, Maria Haustein, et al.Oncotarget|February 11, 2016
Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathwayUdo Walther, Kristin Emmrich, Robert Ramer, et al.Pharmaceutical Research|November 4, 2005
R(+)-methanandamide elicits a cyclooxygenase-2-dependent mitochondrial apoptosis signaling pathway in human neuroglioma cellsKarin Eichele, Ulrike Weinzierl, Robert Ramer, et al.Molecular Pharmacology|September 14, 2004
Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cellsBurkhard Hinz, Robert Ramer, Karin Eichele, et al.Biochemical Pharmacology|July 29, 2014
Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1Maria Haustein, Robert Ramer, Michael Linnebacher, et al.Biochemical Pharmacology|December 6, 2013
Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPKEllen Schmuhl, Robert Ramer, Achim Salamon, et al.Pageof 5